![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Active Filter(s):
Details:
As an exclusive partner, AllianceRx Walgreens Prime is able to offer end-to-end solutions for Leadiant Biosciences and Cystaran patients. Cystaran, a topical ophthalmic therapy for the treatment of corneal cystine crystals in patients with cystinosis.
Lead Product(s): Cysteamine Hydrochloride
Therapeutic Area: Genetic Disease Product Name: Cystaran
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: AllianceRx Walgreens
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership March 22, 2022